Share Price:

APNASPENAspen Pharmacare Hldgs23507-28 (-0.12%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Aspen and Lilly enter into agreement in South Africa and the rest of Sub-Saharan Africa

Stephen Saad, Aspen Group Chief Executive

Subject to approval from relevant Competition Authorities, Lilly will enter a strategic agreement with Aspen to continue serving patients and bring innovative therapies to South Africa and the rest of Sub-Saharan Africa. Johannesburg – In an effort to improve the reach and expand the access of its innovative portfolio of medicines to the patients who… Continue reading Aspen and Lilly enter into agreement in South Africa and the rest of Sub-Saharan Africa

Aspen’s Eastern Cape Value Add

An insight from Stavros Nicolaou into Aspen’s outreach efforts over FY 2022 in the Eastern Cape, South Africa,

Aspen manufactures Africa’s first generic ARVs

Pretoria – Aspen Pharmacare, Southern Africa’s largest generics manufacturer and JSE Securities Exchange listed pharmaceutical company, has announced the launch of Aspen-Stavudine – the first generic antiretroviral (ARV) drug developed and manufactured in Africa. Stephen Saad, Aspen Pharmacare Group Chief Executive Officer said “Aspen-Stavudine is the first locally developed and manufactured generic ARV which presents… Continue reading Aspen manufactures Africa’s first generic ARVs

Boehringer Ingelheim grants a voluntary license for nevirapine to South African company Aspen Pharmacare

South Africa – Boehringer Ingelheim South Africa announced today that it has granted a voluntary license to the South African pharmaceutical manufacturer Aspen Pharmacare for the production, distribution and sale of the antiretroviral nevirapine (marketed world wide by Boehringer Ingelheim as VIRAMUNE). It is the first time that Boehringer Ingelheim has granted a non-exclusive voluntary… Continue reading Boehringer Ingelheim grants a voluntary license for nevirapine to South African company Aspen Pharmacare

World-Class Oral Contraceptive Facility opened

East London – Bevan Gogwana, MEC for health in the Eastern Cape officially opened Aspen Pharmacare’s Oral Contraceptive manufacturing facility earlier today. Stephen Saad, Group Chief Executive of Aspen Pharmacare, Southern Africa’s largest JSE-listed pharmaceutical company, said “the world-class oral contraceptive facility has been designed, built and validated to European standards, and has the capacity… Continue reading World-Class Oral Contraceptive Facility opened

Nelson Mandela opens Engobo Healthcare Centre

Engcobo, Umtata: Ex-president Nelson Mandela officially opened the Engcobo Community Healthcare Centre located outside Umtata earlier today.    Aspen Pharmacare, Southern Africa’s largest JSE-listed pharmaceutical company, has funded the multi-million rand healthcare facility. Stephen Saad, Group Chief Executive of Aspen Pharmacare said “we are strategically positioned to supply a vast range of pharmaceuticals, including low… Continue reading Nelson Mandela opens Engobo Healthcare Centre

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.